EP3759083
2,4-Díamínókínasólín-afleiður og notkun á þeim við meðhöndlun á veirusýkingum, krabbameini eða ofnæmi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.2.2019EP published:
4.5.2022EP application number:
19708817.2
EP translation filed:
15.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
27.2.2039Expiry date:
27.2.2025
Title in English:
2,4-DIAMINOQUINAZOLINE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF VIRUS INFECTIONS, CANCER OR ALLERGIESLanguage of the patent:
English
Timeline
Today
28.2.2019EP application
4.5.2022EP Publication
15.6.2022Translation submitted
15.7.2022Registration published
27.2.2025Expires
Owner
Name:
Janssen Sciences Ireland Unlimited CompanyAddress:
Barnahely, Ringaskiddy, Co Cork, IE
Inventor
Name:
MC GOWAN, David, CraigAddress:
2340 Beerse, BE
Name:
EMBRECHTS, Werner, Constant, JohanAddress:
2340 Beerse, BE
Name:
GUILLEMONT, Jérôme, Émile, GeorgesAddress:
92787 Issy-les-Moulineaux Cedex 9, FR
Name:
COOYMANS, Ludwig, PaulAddress:
2340 Beerse, BE
Name:
JONCKERS, Tim, Hugo, MariaAddress:
2340 Beerse, BE
Name:
RABOISSON, Pierre, Jean-Marie, BernardAddress:
1300 Wavre, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
18159583Date:
1.3.2018Country:
EP
Classification
Categories:
C07D 239/95, A61K 31/517, A61P 1/16, A61P 37/06, A61P 35/00, A61P 31/12
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 5.1.2023
Expires: 27.2.2024
Payer: Árnason Faktor ehf.
Number: 5
Paid: 5.1.2023
Expires: 27.2.2024
Payer: Árnason Faktor ehf.
Number: 5
Paid: 5.1.2023
Expires: 27.2.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 9.1.2024
Expires: 27.2.2025
Payer: Árnason Faktor ehf.